-
Yes, We Really Are Having More Headaches Right Now — Here’s Why
People can experience stress in different ways during the pandemic. Many of those experiences can trigger headaches. Coronavirus Cases in India breaking news updates on Coronavirus in India Coronavirus updates Latest Coronavirus News Coronavirus new cases outbreak of coronavirus disease (COVID-19)
-
When This War Is Over, Many of Us Will Leave Medicine
One ER physician recounts the stress of constant intubations and PPE shortages. This is how we get infected. This is how we die. clinical trials coronavirus ongoing trials Coronavirus Cases in India breaking news updates on Coronavirus in India Coronavirus updates Latest Coronavirus News Coronavirus new cases outbreak of coronavirus disease (COVID-19)
-
What Survival Experts Say About Quarantine Baking
It’s all about competence, confidence, and control. A concrete feeling of accomplishment is something that many of us were lacking even before the novel coronavirus emerged, says John Hudson, chief survival instructor for the British military.
-
It Will Get Easier
These two ‘superpowers’ in your brain can kick into high gear during quarantine, making the adjustment more tolerable. COVID-19 clinical trials coronavirus ongoing trials Coronavirus Cases in India breaking news updates on Coronavirus in India Coronavirus updates Latest Coronavirus News Coronavirus new cases outbreak of coronavirus disease (COVID-19)
-
Trio of Indian pharmaceuticals millionaires launched 130 oncology generics [Taj Pharma] - chemotherapy drugs
Owners of Taj Pharmaceuticals have launched 130 innovative oncology to increase patient access their options for chemotherapy drugs Indian pharmaceuticals businessmen Abhishek Singh, Taj Pharmaceuticals Limited and Priyanka Singh could be in for a major windfall as one of Indian’s leading oncology care division manufacturing groups old unit is to be put up for sale…
-
Shantanu Kumar Singh – Executive Director – Taj Pharma Mumbai
The past two decades in pharmaceuticals and life sciences has been a rather rewarding for the industry with several patent expiry and first generations bio-similar in the industry. The conventional model of pharmaceuticals industry to market the products in the traditional model may not work anymore. The industry has seen several new laws for doctors…